ADAC sees higher revenue and income

Nuclear medicine and information systems vendor ADAC Laboratoriesreported sharply higher sales and net income for its second quarter(end-March). The Milpitas, CA, company posted revenues of $58.4million, a company record, compared with revenues of $44.7 millionin the second quarter of 1995. Net income rose to $3.9 million,compared with $2.8 million in the corresponding period a yearago.

Bookings also increased, jumping 36% to $61 million and addingto the company's backlog. Nuclear medicine product bookings were$40 million for the quarter, a strong increase over the $31 millionin the same period last year but lower than the $48 million inthe first quarter of 1996. ADAC chairman and CEO David Lowe saidthat the drop was most likely due to a seasonal softening of theU.S. nuclear medicine market, as well as a reduction in servicecontract renewals commonly experienced in the second quarter.